The chemical industry has much to learn from the cosmetics and pharmaceutical industries about the replacement of animal tests
Get full access to this article
View all access options for this article.
References
1.
Allergan, Inc. (2011). Allergan Receives FDA Approval for First-of-its-kind, Fully In Vitro, Cell-based Assay for BOTOX® and BOTOX® Cosmetic (onabotulinumtoxinA) [Press release, 24.06.11]. Available at: http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=587234 (Accessed 14.12.12).
2.
BottrillK. (2003). Growing old disgracefully: The cosmetic use of botulinum toxin.ATLA31, 381–391.
3.
National Research Council (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy,216pp. Washington, DC, USA: The National Academies Press.
RovidaC. & HartungT. (2009). Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals — A report by the Transatlantic Think Tank for Toxicology (t4). ALTEX26, 187–208.
